Who
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $3,141
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 Jan 2026
- Last trade
- 28 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 28 Aug 2026 | BIVI BioVieBiotechnology | SEC FORM 4 Bought | $1,570727 at $2.16 | filing |
| 28 Aug 2026filed 28 Aug 2026 | BIVI BioVieBiotechnology | SEC FORM 4 Bought | $1,570727 at $2.16 | filing |
| 5 Jan 2026filed 9 Jan 2026 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,500 at $0.00 | filing |
| 5 Jan 2026filed 9 Jan 2026 | BIVI BioVieoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,500 at $0.00 | filing |
News
BioVie reports positive Phase 2 Parkinson's data for bezisterimBIVI · proactiveinvestors.com · 20 Oct 2026BioVie's Bezisterim Shows Positive Signals In Long COVID Patients With Greater Symptom BurdenBIVI · rttnews.com · 19 Oct 2026BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroupsBIVI · proactiveinvestors.com · 19 Oct 2026
0 headlines in the last 90 days name Amy Suzon Chappell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.